Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 33
1990 58
1991 102
1992 117
1993 110
1994 124
1995 166
1996 197
1997 200
1998 178
1999 188
2000 147
2001 144
2002 135
2003 134
2004 113
2005 125
2006 125
2007 128
2008 123
2009 125
2010 128
2011 115
2012 117
2013 115
2014 111
2015 103
2016 115
2017 88
2018 101
2019 103
2020 92
2021 98
2022 108
2023 100
2024 100
2025 96
2026 56

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,214 results

Results by year

Filters applied: . Clear all
Page 1
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
Avery RK, Alain S, Alexander BD, Blumberg EA, Chemaly RF, Cordonnier C, Duarte RF, Florescu DF, Kamar N, Kumar D, Maertens J, Marty FM, Papanicolaou GA, Silveira FP, Witzke O, Wu J, Sundberg AK, Fournier M; SOLSTICE Trial Investigators. Avery RK, et al. Clin Infect Dis. 2022 Sep 10;75(4):690-701. doi: 10.1093/cid/ciab988. Clin Infect Dis. 2022. PMID: 34864943 Free PMC article. Clinical Trial.
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
Papanicolaou GA, Avery RK, Cordonnier C, Duarte RF, Haider S, Maertens J, Peggs KS, Solano C, Young JH, Fournier M, Murray RA, Wu J, Winston DJ; AURORA Trial Investigators. Papanicolaou GA, et al. Clin Infect Dis. 2024 Mar 20;78(3):562-572. doi: 10.1093/cid/ciad709. Clin Infect Dis. 2024. PMID: 38036487 Free PMC article. Clinical Trial.
Synthetic super-enhancers enable precision viral immunotherapy.
Koeber U, Matjusaitis M, Alfazema N, Furlong K, Wang Z, White R, Hamdan A, Dewari P, Morisse G, Navarette M, Willis R, Wang J, Clark MP, Jacinto de Sousa C, Hong HI, Sheraz S, Southgate B, Cholewa-Waclaw J, Gogolok S, Morrison GM, Cancino FG, Robertson F, Williams A, Rosser SJ, Brennan PM, Sieger D, Soufi A, Quezada SA, Pollard SM. Koeber U, et al. Nature. 2026 May;653(8113):232-241. doi: 10.1038/s41586-026-10329-6. Epub 2026 Apr 8. Nature. 2026. PMID: 41951744 Free PMC article.
4,214 results